|Item#||Name||Size & Form||Brand||Price||Retail||Actions|
The pioneers in carnitine research, Sigma-tau HealthScience Inc., offer GPLC with increased carnitine bioavailability, targeting muscles, heart, and blood vessels. Patented PEAK ATP is the first orally active form of the energy producing molecule adenosine triphosphate (ATP). Since ATP can be degraded by stomach acids, the tablets have been enteric coated to ensure delivery of Peak ATP into the small intestine for maximum bioavailability.
*Statements on this site have not been evaluated by the Food and Drug Administration. Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice. The majority of the product information has been reprinted from the manufacturer.